| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |